FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/10/010048 [Registered on: 09/10/2017] Trial Registered Retrospectively
Last Modified On: 06/10/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   combined effectiveness of ashoka valkala kshirapaka and mustaamruthadi kashaya in Asrigdara (Dysfunctional Uterine Bleeding) 
Scientific Title of Study   Clinical Evaluation Of Combined Effectiveness Of Ashoka Valkala Kshirapaka And Musthamruthadi Kashaya In Asrigdara 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Surya Santhosh C 
Designation  Second Year PG scholar 
Affiliation  Sri Dharmasthala Manjunatheshwara College Of Ayurveda Hassan 
Address  Dr Surya Santhosh C Second Year Pg Scholar Department Of Prasuti Tantra And Stri Roga Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital BM ROAD Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  8861767496  
Fax  08172-256464  
Email  drsuryasanthosh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gayathri Bhat N V 
Designation  Professor 
Affiliation  Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan 
Address  Dr Gayathri Bhat N V Professor Department Of Prasuti Tantra And Stri Roga Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital BM ROAD Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  9844437917  
Fax  08172-256464  
Email  gaya3hassan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gayathri Bhat N V 
Designation  Professor 
Affiliation  Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan 
Address  Dr Gayathri Bhat N V Professor Department Of Prasuti Tantra And Stri Roga Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital BM ROAD Thanniruhalla Hassan

Hassan
KARNATAKA
573201
India 
Phone  9844437917  
Fax  08172-256464  
Email  gaya3hassan@gmail.com  
 
Source of Monetary or Material Support  
Sri Dharemasthala Manjunatheshwatra College of Ayurveda And Hospital BM Road Thanniruhalla Hassan 573201 Karnataka India sdmcah@gmail.com 
 
Primary Sponsor  
Name  Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan 
Address  Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan 573201 Karnataka 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Surya Santhosh C  Sri Dharmasthala Mnjunatheshwara College Of Ayurveda And Hospital Hassan  Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital, Opd No 16,Department of Prasuti Tantra and Stri Roga B M Road Thanniruhalla Hassan 573201 Karnataka India
Hassan
KARNATAKA 
8861767496
08172-256464
sdmcah@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutionl Ethics committee,Sri Dharmasthala Manjunatheshwara college of ayurveda and hospital, B M Road Thanniruhalla , hassan-573201,Karnataka, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Asrigdara Dysfunctional Uterine Bleeding,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ashoka Valkala Kshirapaka And Musthamruthadi Kashaya  Ashoka Valkala Kshirapaka Ashoka Valkala Kshirapaka Will Be Given 96ml In Divided Dose Musthamruthadi Kashaya Musthamruthadi Kashaya Will Be Given 15ml Kashaya Thrice Daily With Eaqual Quantity Of Water for 2 months 
Comparator Agent  not applicable  not applicable 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Patients Aged Between 16 To 50 Years
Those Patients Who Are Ready To Sign Informed Consent Form
 
 
ExclusionCriteria 
Details  UTRINE POLYP
CARCINOMA OF CERVIX
FIBROID UTERUS
COAGULATION DISORDERS
HYPOTHYROIDISM
THREATENED SPONTANEOUS INCOMPLETE ABORTION
ECTOPIC PREGNANCY
ISCHEMIC HEART DISEASE
DIABETES MELLITUS 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment Of Parameters Will be done on Review on 15 days During treatment for 2 months and follow up after treatment for 1 month  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
None  None 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/02/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   will be done in due course of study 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   need for study states that asrigdara is the most common gyaenecological problems faced by women during their active reproductive period which causessignificant discomfort and stress for the women as well as her family. for the diseases of yoni that to for asrigdara apana vata is consider as primary cause and it is said that without vitiation of vata, manifestation of yoni roga are not possible.in ayurveda we gets various treatment in the management of asrigdara namely swarasa, choorna etc.charaka acharya explained it to be treated on the lines of raktatisara, raktapitta and raktarsha. hence ashoka valkala khirapaka and musthamruthadi kashaya taken in the treatment for asrigdara.
Review of literature comprises of all the classical references regarding asrigdara the details of the drug along with botanical name part used and proportion has been explained along with the preparation method and method of administration of both the formulations.
Materials and methods gives an idea regarding source of data which will be 30 patients from inpatient and outpatient departments of sri dharmasthala manjunatheshwara college of ayurveda and hospital, hassan who fulfill the daignostic criteria,inclusion criteria where in patients suffering from asrigdara will be taken
next in plan of study, this is a exploratory single arm open labelled clinical trial at out patient department level.ashoka valkala kshirapaka and musthamrithadi kashaya will be advised orally for 30 days, patient asked to review after 15 days to know the patient condition as well as the drug action. Total duration of administration of ashoka valkala kshirapaka and musthamrithadi kashaya is 2 months and follow up for 1 month.during follow up study reduction in the severity,duration of symptoms will be assessed basing on scoring system. it will be analysed using appropriate statistical test.Demographic data and other relevant information will be analysed with descriptive statistics.
 
Close